| Dir : /home/ithome/mail/new/ |
| Server: Linux host100322.itwesthosting.com 3.10.0-1160.144.1.el7.tuxcare.els4.x86_64 #1 SMP Tue Apr 7 08:40:40 UTC 2026 x86_64 IP: 144.91.64.173 |
| Dir : /home/ithome/mail/new/1774074386.M101737P6084.host100322.itwesthosting.com,S=10220,W=10377 |
Return-Path: <journalium@manusubmit.net>
Delivered-To: ithome@host100322.itwesthosting.com
Received: from host100322.itwesthosting.com
by host100322.itwesthosting.com with LMTP
id 4P7jBRI6vmnEFwAAp0YrwQ
(envelope-from <journalium@manusubmit.net>)
for <ithome@host100322.itwesthosting.com>; Sat, 21 Mar 2026 07:26:26 +0100
Return-path: <journalium@manusubmit.net>
Envelope-to: senka.rendulic@bolnica-lipik.hr
Delivery-date: Sat, 21 Mar 2026 07:26:26 +0100
Received: from postal1.manusubmit.net ([188.165.4.9]:60723 helo=postal3.manusubmit.net)
by host100322.itwesthosting.com with esmtps (TLS1.2) tls TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384
(Exim 4.96.2)
(envelope-from <journalium@manusubmit.net>)
id 1w3pn1-0001fC-1Z
for senka.rendulic@bolnica-lipik.hr;
Sat, 21 Mar 2026 07:26:26 +0100
DKIM-Signature: v=1; a=rsa-sha256; q=dns/txt; c=relaxed/relaxed;
d=manusubmit.net; s=mail; h=Message-ID:Date:Content-Transfer-Encoding:
Content-Type:Subject:To:Reply-To:From:MIME-Version:Sender:Cc:Content-ID:
Content-Description:Resent-Date:Resent-From:Resent-Sender:Resent-To:Resent-Cc
:Resent-Message-ID:In-Reply-To:References:List-Id:List-Help:List-Unsubscribe:
List-Subscribe:List-Post:List-Owner:List-Archive;
bh=2EwoRG+51WJ981ZMv0Wo45OAsOHcdOB0Mt1OrXklQeY=; b=cinSiBRn6G8HUSmdWm0m5ePLGK
ht1N2kGj54sHYp1XMog0llsOc/XQXZesvGz4c7UZ87cfpWB98LSdDp1nczQx/ORPmw3Id/kI0vjHH
Y+5ZsnE6MmvdF5vQtdAarFAbcWNVIHs5Wg8uARl7UijckGW3B5cm/H6N7mxf8EsJa1PI=;
Received: from [205.254.169.249] (helo=DESKTOPDQSU7NM)
by postal.manusubmit.net with esmtpa (Exim 4.92)
(envelope-from <journalium@manusubmit.net>)
id 1w3pmx-0003Yk-T8
for senka.rendulic@bolnica-lipik.hr; Sat, 21 Mar 2026 02:26:24 -0400
MIME-Version: 1.0
From: "journalium@manusubmit.net" <journalium@manusubmit.net>
Reply-To: journalium@manusubmit.net
To: senka.rendulic@bolnica-lipik.hr
Subject: =?windows-1252?Q?senka.rendulic@bolnica-lipik.hr_|_Disease_Activi?=
=?windows-1252?Q?ty,_Inflammation_Markers,_and_Quality_of_Life_Are_Associ?=
=?windows-1252?Q?ated_with_Muscle_Strength_in_Croatian_Rheumatoid_Arthrit?=
=?windows-1252?Q?is_Patients=97A_National-Based_Study?=
Content-Type: text/html; charset="windows-1252"
Content-Transfer-Encoding: quoted-printable
Date: Sat, 21 Mar 2026 11:56:20 +0530
Message-ID: <38364765513521108220371@DESKTOP-DQSU7NM>
X-Spam-Status: No, score=0.5
X-Spam-Score: 5
X-Spam-Bar: /
X-Ham-Report: Spam detection software, running on the system "host100322.itwesthosting.com",
has NOT identified this incoming email as spam. The original
message has been attached to this so you can view it or label
similar future email. If you have any questions, see
root\@localhost for details.
Content preview: To Senka Renduli? Slivar, This is a polite follow-up. We
sent you a message about your article submission on the date shown below.
We tried to get in touch with you, but we're not sure if we were able to or
if you didn't get o [...]
Content analysis details: (0.5 points, 5.0 required)
pts rule name description
---- ---------------------- --------------------------------------------------
0.0 URIBL_BLOCKED ADMINISTRATOR NOTICE: The query to URIBL was
blocked. See
http://wiki.apache.org/spamassassin/DnsBlocklists#dnsbl-block
for more information.
[URIs: doi.org]
-0.0 SPF_PASS SPF: sender matches SPF record
0.0 RCVD_IN_VALIDITY_CERTIFIED_BLOCKED RBL: ADMINISTRATOR NOTICE:
The query to Validity was blocked. See
https://knowledge.validity.com/hc/en-us/articles/20961730681243
for more information.
[188.165.4.9 listed in sa-trusted.bondedsender.org]
0.1 MIME_HTML_ONLY BODY: Message only has text/html MIME parts
0.0 HTML_MESSAGE BODY: HTML included in message
-0.1 DKIM_VALID Message has at least one valid DKIM or DK signature
-0.1 DKIM_VALID_EF Message has a valid DKIM or DK signature from
envelope-from domain
0.1 DKIM_SIGNED Message has a DKIM or DK signature, not necessarily
valid
-0.1 DKIM_VALID_AU Message has a valid DKIM or DK signature from
author's domain
0.0 RCVD_IN_VALIDITY_RPBL_BLOCKED RBL: ADMINISTRATOR NOTICE: The
query to Validity was blocked. See
https://knowledge.validity.com/hc/en-us/articles/20961730681243
for more information.
[188.165.4.9 listed in bl.score.senderscore.com]
0.0 KAM_SHORT Use of a URL Shortener for very short URL
0.6 HTML_MIME_NO_HTML_TAG HTML-only message, but there is no HTML
tag
X-Spam-Flag: NO
X-From-Rewrite: unmodified, forwarded message
<head> =0A<meta http-equiv=3D"Content-Type" content=3D"text/html; charset=
=3Dwindows-1252"> =0A =0A<meta name=3D"GENERATOR" content=3D"MSHTML 11.00.1=
0570.1001"></head> =0A<body><span style=3D'line-height: 107%; font-family: =
"Times New Roman","serif"; font-size: 12pt; mso-fareast-font-family: "Times=
New Roman"; mso-ansi-language: EN-IN; mso-fareast-language: EN-IN; mso-bid=
i-language: AR-SA;'><strong>To Senka Renduli=3F Slivar,</strong></span><spa=
n style=3D'line-height: 107%; font-family: "Times New Roman","serif"; font-=
size: 12pt; mso-fareast-font-family: "Times New Roman"; mso-ansi-language: =
EN-IN; mso-fareast-language: EN-IN; mso-bidi-language: AR-SA;'> <br>=0A<br>=
=0AThis is a polite follow-up. We sent you a message about your article sub=
mission=0Aon the date shown below. We tried to get in touch with you, but w=
e're not sure=0Aif we were able to or if you didn't get our invitations. <b=
r>=0A<br>=0AIf it was an accident, please check those emails and send back =
your manuscript=0Asubmission or publication requirements and a cover letter=
as soon as you can. <br>=0A<br>=0A<b style=3D"mso-bidi-font-weight: normal=
;">Link to Submit: <u><span style=3D"color: rgb(0, 176, 80);">https://doi.o=
rg/10.29328/journal.ijbmr</span></u></b> <br>=0A<br>=0AThe last day to send=
in submissions is <b style=3D"mso-bidi-font-weight: normal;">April=0A02, 2=
026</b> <b style=3D"mso-bidi-font-weight: normal;">(Rolling submissions may=
be=0Aaccepted.)</b> <br>=0A<br>=0AWe need your answer so that we don't hav=
e to follow up. <br>=0A<br>=0A<b style=3D"mso-bidi-font-weight: normal;">Ki=
nd regards,</b> <br>=0AFranklin Mavis<br>=0A<b style=3D"mso-bidi-font-weigh=
t: normal;"><span style=3D"color: rgb(0, 112, 192);">International Journal =
of Bone Marrow Research (ISSN 2994-2594)</span></b><br>=0A_________________=
_______________________ <br>=0ASent on Wednesday, October 03, 2025, at 11:2=
5:38 AM <br>=0ATo: senka.rendulic@bolnica-lipik.hr <br>=0ASubject: Re: IJBM=
R | senka.rendulic@bolnica-lipik.hr <br>=0A<br>=0A<b style=3D"mso-bidi-font=
-weight: normal;">Hey, Senka Renduli=3F Slivar</b> <br>=0A<br>=0AI hope thi=
s email finds you well and happy. We think it's time to get in touch=0Awith=
authors about their submissions after a long time has passed. This will=0A=
help us better understand their place in the scientific community. <br>=0A<=
br>=0AWe kindly ask that you turn in your work by the deadline on behalf of=
the=0Adistinguished editorial board. <br>=0A<br>=0AYou were told about it =
before, but you couldn't get the submission because you=0Awere too busy. Bu=
t a response can stop pointless follow-ups or even spam=0Aemails. <br>=0A<b=
r>=0AThe journal would really appreciate it if you sent in a paper on somet=
hing=0Ayou're interested in right now. They want to publish high-quality wo=
rk. We=0Abelieve that your points of view would be very helpful in the disc=
ussions we=0Aare having in our field right now. <br>=0A<br>=0APlease let us=
know if you have any questions about the rules or need help with=0Athe sub=
mission process. <br>=0A<br>=0A<b style=3D"mso-bidi-font-weight: normal;">P=
lease pay attention:</b> <br>=0A<br>=0A<b style=3D"mso-bidi-font-weight: no=
rmal;">1.</b> This timeline is needed to make a=0Agood submission. <br>=0A<=
br>=0A<b style=3D"mso-bidi-font-weight: normal;">2.</b> Submissions that co=
me in over=0Atime are fine. <br>=0A<br>=0A<b style=3D"mso-bidi-font-weight:=
normal;">3.</b> The author can ask for more time=0Ato turn in their work. =
<br>=0A<br>=0A<b style=3D"mso-bidi-font-weight: normal;">4.</b> After being=
looked over, any type=0Aof article will be considered for publication. <br=
>=0A<br>=0A<b style=3D"mso-bidi-font-weight: normal;">5.</b> You will get s=
creenshots of the=0Areview correspondence if the author asks for them. <br>=
=0A<br>=0A<b style=3D"mso-bidi-font-weight: normal;">6.</b> We are doing ev=
erything we can to=0Amake the process clear and fair. <br>=0A<br>=0AWe woul=
d really appreciate it if you could answer this email or send us a paper=0A=
to read. We are sure that your knowledge will show in our next issue. <br>=
=0A<br>=0AWe expect an acceptance and response within a day so we don't hav=
e to send out=0Aanother email. <br>=0A<br>=0A<b style=3D"mso-bidi-font-weig=
ht: normal;">Best wishes,</b> <br>=0A<b style=3D"mso-bidi-font-weight: norm=
al;"><span style=3D"color: rgb(0, 112, 192);">International Journal of Bone=
Marrow Research (ISSN 2994-2594)</span></b><br>=0AFranklin Mavis<br>=0A<sp=
an style=3D"color: rgb(166, 166, 166); mso-themecolor: background1; mso-the=
meshade: 166;">|EID1084-IJBMR|</span>=0A<br>=0A<br>=0A</span><span style=3D=
'line-height: 107%; font-family: "Times New Roman","serif"; font-size: 10pt=
; mso-fareast-font-family: "Times New Roman"; mso-ansi-language: EN-IN; mso=
-fareast-language: EN-IN; mso-bidi-language: AR-SA;'>Sometimes, our editori=
al office gets in touch=0Awith researchers whose work is published in publi=
cly available academic=0Ajournals.Please reply with "Unsubscribe" if you do=
n't want to get=0Athese kinds of emails in the future. We will quickly remo=
ve your email address=0Afrom our database.</span></body>